Cancer.Net Associate Editor: Central Nervous System Tumors
Comprehensive Cancer Center of Wake Forest University
Dr. Glenn Lesser is the inaugural Louise McMichael Miracle Professor and Associate Chief in the section on Hematology and Oncology in the Department of Internal Medicine at Wake Forest, with joint appointments in the Departments of Anesthesiology, Neurosurgery, and Public Health Sciences. His clinical and research interests include the development of novel therapeutic agents to treat adult malignant brain tumors and symptom management issues experienced by people with cancer.
Dr. Lesser completed his undergraduate education at Duke University, received his medical degree from Pennsylvania State Hershey College of Medicine, and finished his Internal Medicine residency at Wake Forest Baptist Medical Center. He completed a fellowship in Medical Oncology at Johns Hopkins Oncology Center before returning to Wake Forest as the Director of Medical Neuro-Oncology.
Dr. Lesser is the contact Multi-Principal Investigator of the Wake Forest NCORP Research Base, one of only two National Cancer Institute (NCI) funded Cancer Center NCORP Research Bases in the country charged with pursuing cancer control (i.e. symptom prevention and symptom treatment) and cancer care delivery of clinical trials in community oncology practices across the United States. He is also the co-chair of the NCI Symptom Management and Quality of Life Steering Committee, which reviews all national oncology cooperative group cancer control clinical trial proposals. He is the Co-Program leader of the Neuro-Oncology Research Program of the Wake Forest Baptist Comprehensive Cancer Center and a recent recipient of Wake Forest’s Byrum Distinguished Faculty Mentor award. Dr. Lesser is also the Neuro-Oncology section editor of Current Treatment Options in Oncology and a member of the editorial board of Neuro-Oncology Practice.
View current ASCO disclosure here.
Last Updated: October 2019